Cargando…

Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis

OBJECTIVE: To evaluate the efficacy and safety of omalizumab in the treatment of severe or uncontrolled allergic diseases in children. METHODS: We conducted a systematic search of the PubMed, Embase, CENTRAL, and clinicaltrials.gov databases up to 23rd July 2021, with no language limitations. Random...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ling, Zhou, Pengxiang, Wang, Zhenhuan, Zhai, Suodi, Zhou, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965060/ https://www.ncbi.nlm.nih.gov/pubmed/35372142 http://dx.doi.org/10.3389/fped.2022.851177

Ejemplares similares

Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis
por: Zhou, Pengxiang, et al.
Publicado: (2022)

Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile
por: Fenu, Grazia, et al.
Publicado: (2023)

Extended or Continuous Infusion of Carbapenems in Children with Severe Infections: A Systematic Review and Narrative Synthesis
por: Zhou, Pengxiang, et al.
Publicado: (2021)

Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review
por: Zheng, Chen, et al.
Publicado: (2023)

Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
por: Aguiar, Rita, et al.
Publicado: (2014)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Therapeutic efficacy of omalizumab in children with moderate-to-severe allergic asthma combined with chronic sinusitis
por: Chong, Weikun, et al.
Publicado: (2023)

Case Report: Off-Label Use of Omalizumab in a 6-Year-Old Boy With ASD Ameliorated Severe Allergic Rhinitis and Subsequently Improved Behavioral Symptoms
por: Kong, Xue-Jun, et al.
Publicado: (2021)

Omalizumab in children with severe allergic disease: a case series
por: Crisafulli, Giuseppe, et al.
Publicado: (2019)

Cefepime Efficacy and Safety in Children: A Systematic Review and Meta-analysis
por: Jan, Saber, et al.
Publicado: (2018)

Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
por: Lai, Tianwen, et al.
Publicado: (2015)

Intravenous Parecoxib for Pain Relief after Orthopedic Surgery: A Systematic Review and Meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2022)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Efficacy and Safety of Stem Cell Therapy in Children With Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
por: Qu, Jiayang, et al.
Publicado: (2022)

Investigation of Allergic Sensitizations in Children With Allergic Rhinitis and/or Asthma
por: Dai, Lingman, et al.
Publicado: (2022)

Omalizumab in Children with Severe Allergic Asthma: The Italian Real-Life Experience
por: Licari, Amelia, et al.
Publicado: (2017)

Omalizumab and unmet needs in severe asthma and allergic comorbidities in Japanese children
por: Nishima, Sankei, et al.
Publicado: (2019)

Omalizumab for the treatment of severe allergic asthma in children: A tale of two
por: Brannick, Sinéad, et al.
Publicado: (2022)

Corrigendum: Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
por: Lai, Tianwen, et al.
Publicado: (2015)

Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
por: Kotoulas, Serafeim Chrysovalantis, et al.
Publicado: (2022)

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
por: Zhou, Pengxiang, et al.
Publicado: (2021)

Intravenous ibuprofen in postoperative pain and fever management in adults: A systematic review and meta‐analysis of randomized controlled trials
por: Zhou, Pengxiang, et al.
Publicado: (2023)

Sex, Allergic Diseases and Omalizumab
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review
por: Cai, Cuihong, et al.
Publicado: (2023)

Case Report: Self-Administration of Omalizumab in an Adolescent With Severe Asthma During SARS-CoV-2 Infection
por: Paladini, Erika, et al.
Publicado: (2021)

Pediatric tuina for allergic rhinitis in children: A systematic review and meta-analysis of randomized controlled trials
por: Fu, Shifang, et al.
Publicado: (2022)

Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma
por: Henriksen, Daniel P., et al.
Publicado: (2020)

The correlation between tic disorders and allergic conditions in children: A systematic review and meta-analysis of observational studies
por: Chang, Ying, et al.
Publicado: (2023)

Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)

Lactate dehydrogenase and the severity of adenoviral pneumonia in children: A meta-analysis
por: Zou, Min, et al.
Publicado: (2023)

The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review
por: Marrapodi, Maria Maddalena, et al.
Publicado: (2023)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
por: Zhang, Yahui, et al.
Publicado: (2021)

Efficacy and safety of omalizumab treatment to facilitate successful oral desensitisation in high-risk milk-allergic patients
por: Aguiar, Rita, et al.
Publicado: (2015)

Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic
por: Kirchnerová, Olga Růžičková, et al.
Publicado: (2018)

Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
por: Lambert, Nathalie, et al.
Publicado: (2015)

An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases
por: Liu, Peipei, et al.
Publicado: (2020)

Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
por: Torres-Duque, Carlos A., et al.
Publicado: (2022)

Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
por: Tajiri, Tomoko, et al.
Publicado: (2023)

Effective omalizumab treatment influenced eosinophil function in severe allergic asthmatics
por: Yan, Huacheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6o1ic2qpjgv0qgd3k5p4rdeo2o